DC Chemicals

All products / DC23168

CCT128930
CAT. NO. DC23168

CCT128930

Pack sizes and prices

Pack sizePrice
100 mg$450 USDRequest a quote / confirm availability →
250 mg$900 USDRequest a quote / confirm availability →
1 g$1,800 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

CCT128930 is a potent, selective, ATP-competitive AKT inhibitor with IC50 of 6 nM (AKT2), 28-fold selectivity over the closely related PKA; also exhibits 20-fold selectivity over p70S6K (IC50=120 nM); shows growth inhibition for U87MG human glioblastoma cells (IC50=6.3 uM), for LNCaP human prostate cancer cells (IC50=0.35 uM), and for PC3 human prostate cancer cells (IC50=1.9 uM) consistent with AKT pathway blockade; blocks the phosphorylation of several downstream AKT biomarkers in U87MG tumor xenografts, indicating AKT inhibition in vivo; demonstrates antitumor activity in U87MG and HER2-positive, PIK3CA-mutant BT474 human breast cancer xenografts.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC23168
Product nameCCT128930
CAS885499-61-6
Molecular formulaC18H20ClN5
Molecular weight341.837902069092
Purity>98%
SMILESNC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — CCT128930 (DC23168)

Related research products

Browse newly added products